EMG
EVGN icon

ETF Managers Group’s Evogene EVGN Stock Holding History

ETF Managers Group’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,512
Closed -$110K – 525
2018
Q1 		$110K Buy
+3,512
New +$131K 0.01% 258
2017
Q3 		– Sell
-1,657
Closed -$83K – 468
2017
Q2 		$83K Buy
+1,657
New +$85.6K 0.01% 202

Other funds holding EVGN

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MCM
Moon Capital Management New York $148M AUM 25.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ETF Managers Group's EVGN Position: Q2 2018 in Review

ETF Managers Group sold out of Evogene (EVGN) in Q2 2018, closing a stake of 3,512 shares — an estimated $110K sold.

ETF Managers Group first reported a position in EVGN in Q2 2017 and held it in 2 quarters. The position peaked at $110K in Q1 2018. 24 funds tracked by Wall St. Rank hold EVGN as of Q2 2018.

  • ETF Managers Group reported no remaining Evogene position as of Q2 2018 after selling out during the quarter.
  • ETF Managers Group sold 3,512 Evogene shares in Q2 2018, an estimated $110K.
  • ETF Managers Group first reported a position in Evogene in Q2 2017 and held it in 2 quarters.
  • ETF Managers Group's Evogene position peaked at $110K in Q1 2018.
  • 24 funds tracked by Wall St. Rank held Evogene as of Q2 2018.

Based on ETF Managers Group's 13F filing for Q2 2018, filed 14 Aug 2018.